Position of STAT-1α in cycloheximide-dependent apoptosis triggered by TNF-α in human colorectal COLO 205 cancer cell line; role of polyphenolic compounds

Journal of Physiology and Pharmacology

Volumn 56, Issue SUPPL. 3, 2005, Pages 119-141

  Pajak B ^a   Gajkowska, B ^b   Orzechowski, A ^a  

^a WARSAW UNIVERSITY OF LIFE SCIENCES   (Poland)

^b POLISH ACADEMY OF SCIENCES   (Poland)

Author keywords

Apoptosis; Colorectal cancer; Cycloheximide; Polyphenols; STAT 1 ; TNF

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; APIGENIN; CYCLOHEXIMIDE; FLAVANOL DERIVATIVE; KAEMPFEROL; PROTEIN; PROTEIN STAT 1ALPHA; QUERCETIN DERIVATIVE; STAT1 PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

APOPTOSIS; CANCER CELL CULTURE; CELL FUNCTION; CELL VIABILITY; COLORECTAL CARCINOMA; CONFERENCE PAPER; CONTROLLED STUDY; HUMAN; HUMAN CELL; MOLECULAR DYNAMICS; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; APIGENIN; APOPTOSIS; CASP8 AND FADD-LIKE APOPTOSIS REGULATING PROTEIN; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; CHROMONES; COLORECTAL NEOPLASMS; CYCLOHEXIMIDE; DOSE-RESPONSE RELATIONSHIP, DRUG; FLAVONOIDS; HUMANS; INTERFERON-STIMULATED GENE FACTOR 3; KAEMPFEROLS; LIGANDS; MAP KINASE KINASE KINASES; MORPHOLINES; PHENOLS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; PROTEIN SYNTHESIS INHIBITORS; QUERCETIN; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; SIGNAL TRANSDUCTION; TIME FACTORS; TUMOR ESCAPE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 31144450936     PISSN: 08675910     EISSN: 08675910     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (44)

1. Gruss HJ, Duyster J, Herrmann F. Structural and biological features of the TNF receptor and TNF ligand superfamilies: interactive signals in the pathobiology of Hodgkin's disease. Ann Oncol 1996; 7: 673-682.
2. Herbeuval J-P, Lambert C, Sabido O, Cottier M, Fournel P, Dy M, Genin C. Macrophages from cancer patients: analysis of TRAIL, TRAIL receptors, and colon tumor cell apoptosis. J Natl Cancer Inst 2003; 95: 611-621.
3. Salvesen GS, Dixit VM. Caspase activation: the induced-proximity model. Proc Natl Acad Sci 1999; 96: 10964-10967.
4. Duan H, Dixit VM. RAIDD is a new "death" adaptor molecule. Nature 1997; 385: 86-89.
5. Song HY, Regnier CH, Kirschning CJ, Goeddel DV, Rothe M. Tumor necrosis factor (TNF)-mediated kinase cascades: Bifurcation of Nuclear Factor-κB and c-jun N-terminal kinase (JNK/SAPK) pathways at TNF receptor-associated factor 2. Proc Natl Acad Sci USA 1997; 94: 9792-9796.
6. Krueger A, Baumann S, Krammer PH, Kirchhoff S. FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis. Mol Cell Biol 2001; 21: 8247-8254.
7. Micheau O, Lens S, Gaide O, Alevizopoulos K, Tchopp J. NF-κB signals induce the expression of c-FLIP. Mol Cell Biol 2001; 21: 5299-5305.
8. Xiao CW, Asselin E, Tsang BK. Nuclear factor κB-mediated induction of Flice-like inhibitory protein prevents tumor necrosis factor α-induced apoptosis in rat granuloma cells. Biol Reprod 2002; 67: 436-441.
9. Kataoka T, Tschopp J. N-terminal fragment of c-FLIP(L) processed by caspase 8 specifically interacts with TRAF2 and induces activation of the NF-κB signaling pathway. Mol Cell Biol 2004; 24: 2627-2636.
10. L in colonic adenocarcinoma. J Pathol 2001; 194: 15-19.
11. Bromberg J, Darnell Jr. JE. The role of STATs in transcriptional control and their impact on cellular function. Oncogene 2000; 19: 2468-2473.
12. Chin YE, Kitagawa M, Kuida K, Flavell RA, Fu X-Y. Activation of the STAT signaling pathway can cause expresion of caspase 1 and apoptosis. Mol Cell Biol 1997; 17: 5328-5337.
13. Kumar A, Commane M, Flickinger TW, Horvath CM, Stark GR. Defective TNF-α-induced apoptosis in STAT1-null cells due to low constitutive lkevels of caspases. Science 1997; 278: 1630-1632.
14. Wang Y, Wu TR, Cai S, Welte T, Chin YE. Stat1 as a component of tumor necrosis factor alpha receptor 1-TRADD signaling complex to inhibit NF-κB activation. Mol Cell Biol 2000; 20: 4505-4512.
15. Haque SJ, Flati V, Deb A, Williams BRG. Roles of protein-tyrosine phosphatases in STAT1a-mediated cell signaling. J Biol Chem 1995; 27: 25709-25714.
16. Guo D-Q, Dunbar JD, Yang CH, Pfeffer LM, Donner DB. Induction of Jak/STAT signaling by activation of the type 1 TNF receptor. J Immunol 1998; 160: 2742-2750.
17. Wesemann DR, Benveniste EN. STAT-1α and IFN-γ as modulators of TNF-α signaling in macrophages: regulation and functional implications of the TNF receptor 1:STAT-1α complex. J Immunol 2003; 171: 5313-5319.
18. Wesemann DR, Qin H, Kokorina N, Benveniste EN. TRADD interacts with STAT-1α and influences interferon-γ signaling. Nature Immunol 2004; 5: 199-207.
19. 2-terminal protein kinase, and apoptosis by tumor necrosis factor-a. J Cell Biochem 2002; 84: 803-815.
20. Kreuz S, Siegmund D, Scheurich P, Wajant H. NF-κB inducers upregulate cFLIP, a cycloheximide-sensitive inhibitor of death receptor signaling. Mol Cell Biol 2001; 21: 3964-3973.
21. Semba S, Itoh N, Ito M, Harada M, Yamakava M. The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3′-kinase, in human colon cancer cells. Clin Cancer Res 2002; 8: 1957-1963.
22. Jacobson MD, Burne JF, Raff MC. Programmed cell death and Bcl-2 protection in the absence of a nucleus. EMBO J 1994; 13: 1899-1910.
23. Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal Biochem 1976; 72: 248-254.
24. Paja̧k B, Gajkowska B, Orzechowski A. Cycloheximide-mediated sensitization to TNF-α-induced apoptosis in human colorectal cancer cell line COLO 205; role of FLIP and metabolic inhibitors. J Physiol Pharmacol 2005; 56 S2: xx-xx.
25. French L, Tschopp J. Inhibition of death receptor signaling by FLICE-inhibitory protein as a mechanism for immune escape of tumors. J Exp Med 1999; 190: 891-893.
26. Lin HL, Liu TY, Wu CW, Chi CW. Berberine modulates expression of mdr1 gene product and the responses of digestive tract cancer cells to Paclitaxel. Br J Cancer 1999; 81: 416-422.
27. Molnar J, Mucsi I, Nacsa J, Hever A, Gyemant N, Ugocsai K, Hegyes P, Kiessig S, Gaal D, Lage H, Varga A. New silicon compounds as resistance modifiers against multidrug-resistant cancer cells. Anticancer Res 2004; 24: 865-871.
28. Chen YC, Shen SC, Chow JM, Ko CH, Tseng SW. Flavone inhibition of tumor growth via apoptosis in vitro and in vivo. Int J Oncol 2004; 25: 661-670.
29. Wu TR, Hong YK, Wang X-D, Ling MY, Dragoi AM, Chung AS, Campbell AG, Han Z-Y, Feng G-S, Chin YE. SHP-2 is a dual-speciflty phosphatase involved in STAT1 dephosphorylation at both tyrosine and serine residues in nuclei. J Biol Chem 2002; 277: 47572-47580.
30. Montfort RLM, Congreve M, Tisi D, Carr R, Jhoti H. Oxidation state of the active-site cysteine in protein tyrosine phosphatase 1B. Nature 2003; 423: 773-775.
31. Salmeen A, Andersen JN, Myers MP, Meng T-C, Hinks JA, Tonks NK, Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 2003; 423: 769-773.
32. Muro S, Takemasa I, Oba S, Matoba R, Ueno N, Matuyama C, Yamashita R, Sekimoto M, Yamamoto H, Nakamori S, Monden M, Ishii S, Kato K. Identification of expressed genes linked to malignancy of human colorectal carcinoma by parametric clustering of quantitative expression data. Genome Biol 2003; 4: R21.
33. Richter M, Ebermann R, Marian B. Quercetin-induced apoptosis in colorectal tumor cells: possible role of EGF receptor signaling. Nutr Cancer 1999, 34: 88-99.
34. Fulda S, Meyer E, Debatin K-M. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression. Cancer Res 2000; 60: 3947-3956.
35. Hernandez A, Wang Q-D, Schwartz SA, Evers BM. Sensitization of human colon cancer cells to TRAIL-mediated apoptosis. J Gastrointest Surg 2001; 5: 56-65.
36. L and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide. Blood 2000, 95: 3478-3482.
37. Bronisz A, Gajkowska B, Domanska-Janik K. PKC and Raf-1 inhibition-related apoptotic signalling in N2a cells. J Neurochem 2002; 81: 1176-84.
38. Kwiecińska P, Roszkiewicz B, Łokociejewska M, Orzechowski A. Elevated expression of NF-κB and Bcl-2 proteins in C2C12 myocytes during myogenesis affected by PD98059, LY294002 or SB 203580 treatments. Cell Biol Int 2005; (in press).
39. Lin SY, Chang YT, Liu JD, Yu CH, Ho YS, Lee YH, Lee WS. Molecular mechanisms of apoptosis induced by magnolol in colon and liver cancer cells. Mol Carcinog 2001; 32: 73-83.
40. Dross RV, Xue Y, Knudson A, Pelling JC. The chemopreventive bioflavonoid apigenin modulates signal transduction pathways in keratinocyte and colon carcinoma cell lines. J Nutr 2003; 133: 3800S-3804S.
41. Orzechowski A, Grzelkowska K, Zimowska W, Skierski J, Płoszaj T, Bachanek K, Motyl T, Karlik W, Filipecki M. Induction of apoptosis and NF-κB by quercetin in growing murine L1210 lymphocytic leukaemic cells potentiated by TNF-α. Repr Nutr Dev 2000; 40: 441-564.
42. Ahmed K, Gerber DA, Cochet C. Joining the cell squad: an emerging role for protein kinase CK2. Trends in Cell Biol 2002, 12: 226-230.
43. Ravi R, Bedi A. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Cancer Res 2002, 62: 4180-4185.
44. Raab G, Jacobasch L, Heinevetter F, Maurer S. Role of flavonols and anthocyanins from fruits and vegetables in cancer prevention. In Phytochemicals Phytopharmacology, AOCS Press, 2000, pp. 154-163.